medRxiv PreprintsInternational15 October 2026
Stage-Specific Associations of Automated RPR With Treponema pallidum qPCR Positivity and Cycle Threshold in Early Symptomatic Syphilis: A Multicenter Study Using Specimens Collected During Routine Care
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: Treponema pallidum quantitative polymerase chain reaction (qPCR) positivity and cycle threshold (Ct) by rapid plasma reagin (RPR), disease stage, and other characteristics are poorly characterized in routine-care specimens, leaving it unclear when qPCR of such specimens is informative for diagnosis. Methods: This Japanese multicenter cross-sectional study explored qPCR positivity and Ct by these characteristics. Nonblood specimens collected during routine care underwent qPCR at a central laboratory for this study. Bayesian logistic and normal regressions modeled positivity and mean
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- To TTV or Not to TTV? A Combined Urinary Biomarker Approach in Kidney Transplant Recipients Using Torque Teno Virus, Cell-Free DNA, and BK Polyomavirus Measurements15 October 2026
- How healthcare professionals manage uncertainty around hormone replacement therapy (dis-)continuation: the TAPER qualitative Study15 October 2026
- Wide-angled proteomics in giant cell arteritis reveals complement pathway activation15 October 2026
- Calibration, Uncertainty, and Data Efficiency of Deep Learning Chest Radiograph Classifiers Under Cross-Dataset Distribution Shift: A Multi-Dataset Benchmark15 October 2026
- Knowledge, Attitudes, and Practices Regarding Antimicrobial Resistance Among Users of an Indian Digital Healthcare Platform: A Cross-sectional Online Survey15 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.